Literature DB >> 18592393

Concordance-based adherence support service delivery: consumer perspectives.

Sophie Du Pasquier1, Parisa Aslani.   

Abstract

OBJECTIVES: To explore consumers' attitudes towards, and expectations of, adherence support services in primary health care, specifically in community pharmacy; and to explore consumers' attitudes towards the concept of concordance.
SETTING: An exploratory qualitative study conducted in Metropolitan Sydney, Australia.
METHOD: Three focus group discussions with consumers on chronic therapy (n = 22) and two focus groups with consumer representatives (n = 15) were conducted in 2002. Consumer representatives were peer educators volunteering in an association which promotes quality use of medicines among elderly patients. All discussions were audio-taped, transcribed verbatim and thematically content analysed. MAIN OUTCOME MEASURES: Consumers' experiences with adherence support services delivered by general practitioners and pharmacists, their expectations towards general practitioners' and pharmacists' role in adherence support; and attitudes towards concordance in consultations.
RESULTS: Participants expected an increased provision of medicine information and a reduction in the number of medications taken as the main strategies to promote adherence. They believed that once understandable information had been delivered, it was their responsibility to take their medications as prescribed. Yet participants frequently complained about the information received, especially from doctors. Only a subgroup of participants expected pharmacists to be involved in adherence support services. These participants generally relied on pharmacists for medicine information and were satisfied with the communication process when interacting with the pharmacists. All participants were positive about concordance, because they valued two-way communication and increased consideration of their needs and beliefs by healthcare professionals. However, they were hesitant about being involved in a shared treatment decision-making process. Many participants focused on concordance with doctors and identified barriers to the establishment of concordance: time pressures, financial constraints, the gap of competence and power between patients and doctors.
CONCLUSIONS: Pharmacists should consider consumers' needs for information and establishing concordance, as well as their expectations of the pharmacy profession, in delivering concordance based adherence support services. Given participants' high demand for medicine information, an opportunity might exist for pharmacists to influence consumers' expectations by offering information which is tailored towards their needs.

Entities:  

Mesh:

Year:  2008        PMID: 18592393     DOI: 10.1007/s11096-008-9237-0

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  23 in total

1.  Measuring patients' desire for autonomy: decision making and information-seeking preferences among medical patients.

Authors:  J Ende; L Kazis; A Ash; M A Moskowitz
Journal:  J Gen Intern Med       Date:  1989 Jan-Feb       Impact factor: 5.128

2.  Antihypertensive treatment and patient autonomy--the follow-up appointment as a resource for care.

Authors:  K I Kjellgren; S Svensson; J Ahlner; R Säljö
Journal:  Patient Educ Couns       Date:  2000-04

Review 3.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

4.  A qualitative study of medication-taking behaviour in primary care.

Authors:  J Dowell; H Hudson
Journal:  Fam Pract       Date:  1997-10       Impact factor: 2.267

Review 5.  Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review.

Authors:  Boris Lg Van Wijk; Olaf H Klungel; Eibert R Heerdink; Anthonius de Boer
Journal:  Ann Pharmacother       Date:  2005-01-04       Impact factor: 3.154

Review 6.  Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications.

Authors:  R B Haynes; K A McKibbon; R Kanani
Journal:  Lancet       Date:  1996-08-10       Impact factor: 79.321

7.  Doctor-patient communication about drugs: the evidence for shared decision making.

Authors:  F A Stevenson; C A Barry; N Britten; N Barber; C P Bradley
Journal:  Soc Sci Med       Date:  2000-03       Impact factor: 4.634

8.  Attitudes toward patient expertise in chronic illness.

Authors:  S E Thorne; K Ternulf Nyhlin; B L Paterson
Journal:  Int J Nurs Stud       Date:  2000-08       Impact factor: 5.837

9.  Patient counselling profile in a Finnish pharmacy.

Authors:  Heli Kansanaho; Nina Isonen-Sjölund; Kirsi Pietilä; Marja Airaksinen; Taisto Isonen
Journal:  Patient Educ Couns       Date:  2002-05

10.  Attitudes towards drugs--a survey in the general population.

Authors:  D Isacson; K Bingefors
Journal:  Pharm World Sci       Date:  2002-06
View more
  4 in total

1.  Recognition and control of hypertension, diabetes, and dyslipidemia in patients with systemic lupus erythematosus.

Authors:  Luísa Lima Castro; Cristina Costa Duarte Lanna; Antônio Luiz Pinho Ribeiro; Rosa Weiss Telles
Journal:  Clin Rheumatol       Date:  2018-06-12       Impact factor: 2.980

2.  Recognition and control of hypertension, diabetes, and dyslipidemia in patients with rheumatoid arthritis.

Authors:  Luísa Lima Castro; Cristina Costa Duarte Lanna; Mariana Pimenta Rocha; Antônio Luiz Pinho Ribeiro; Rosa Weiss Telles
Journal:  Rheumatol Int       Date:  2018-06-15       Impact factor: 2.631

Review 3.  Review of community pharmacy services: what is being performed, and where are the opportunities for improvement?

Authors:  Brittany L Melton; Zoe Lai
Journal:  Integr Pharm Res Pract       Date:  2017-03-06

Review 4.  Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners.

Authors:  Lutfun N Hossain; Fernando Fernandez-Llimos; Tim Luckett; Joanna C Moullin; Desire Durks; Lucia Franco-Trigo; Shalom I Benrimoj; Daniel Sabater-Hernández
Journal:  BMJ Open       Date:  2017-09-05       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.